Search Result

Results for "

D3

" in MedChemExpress (MCE) Product Catalog:

By Targets:	17β-HSD (3) 5 alpha Reductase (1) 5-HT Receptor (75) Acetolactate Synthase (ALS) (1) Acyltransferase (1) ADC Cytotoxin (4) Adenosine Receptor (4) Adrenergic Receptor (56) Akt (4) Aldehyde Dehydrogenase (ALDH) (1) Amino Acid Derivatives (5) AMPK (1) Amyloid-β (1) Androgen Receptor (11) Angiotensin Receptor (5) Angiotensin-converting Enzyme (ACE) (7) Antibiotic (65) Antifolate (5) Apoptosis (100) Aryl Hydrocarbon Receptor (5) ASCT (1) ATM/ATR (1) ATP Citrate Lyase (1) Aurora Kinase (1) Autophagy (107) Bacterial (94) Bcl-2 Family (1) Bcr-Abl (4) BCRP (2) Beta-lactamase (1) Biochemical Assay Reagents (2) c-Fms (1) c-Kit (4) Calcium Channel (16) Carbonic Anhydrase (3) Casein Kinase (1) CaSR (2) CD19 (1) CDK (5) CFTR (1) Chloride Channel (1) Cholinesterase (ChE) (13) Complement System (1) COX (45) CRISPR/Cas9 (2) Cuproptosis (1) Cytochrome P450 (13) Dipeptidyl Peptidase (7) DNA Alkylator/Crosslinker (2) DNA/RNA Synthesis (12) Dopamine Receptor (165) Dopamine Transporter (1) Drug Metabolite (50) Dynamin (2) EGFR (4) Elastase (1) Endogenous Metabolite (251) Endothelin Receptor (1) Enolase (1) Enterovirus (1) Estrogen Receptor/ERR (10) FAAH (2) Factor Xa (1) Fatty Acid Synthase (FASN) (1) Ferroptosis (22) FGFR (6) FKBP (1) Flavivirus (1) FLT3 (2) Fungal (23) GABA Receptor (5) Glucocorticoid Receptor (10) Glyoxalase (GLO) (1) GlyT (2) GnRH Receptor (1) GPR109A (1) GSK-3 (2) HBV (2) HCV (7) HCV Protease (1) HDAC (2) Hedgehog (3) HIF/HIF Prolyl-Hydroxylase (2) Histamine Receptor (32) Histone Acetyltransferase (1) Histone Methyltransferase (6) HIV (15) HIV Integrase (5) HIV Protease (2) HMG-CoA Reductase (HMGCR) (11) HSP (4) HSV (1) IFNAR (1) iGluR (8) Imidazoline Receptor (1) Indoleamine 2,3-Dioxygenase (IDO) (1) Influenza Virus (12) Interleukin Related (2) Isotope-Labeled Compounds (1131) JAK (4) JNK (1) Keap1-Nrf2 (4) Leukotriene Receptor (3) Ligands for E3 Ligase (1) LXR (1) mAChR (11) MEK (1) Melatonin Receptor (4) MicroRNA (64) Microtubule/Tubulin (13) Mineralocorticoid Receptor (4) Mitochondrial Metabolism (2) Mitophagy (8) Molecular Glues (2) Monoamine Oxidase (2) mTOR (5) nAChR (3) Neurokinin Receptor (1) NF-κB (11) NO Synthase (3) NOD-like Receptor (NLR) (1) Notch (1) Nucleoside Antimetabolite/Analog (19) Opioid Receptor (5) Orexin Receptor (OX Receptor) (1) Orthopoxvirus (1) P-glycoprotein (3) P2Y Receptor (2) p38 MAPK (4) PAK (3) Parasite (39) PARP (1) PDGFR (10) PERK (1) PGE synthase (1) Phosphatase (3) Phosphodiesterase (PDE) (16) Phospholipase (3) PI3K (6) PKC (1) Potassium Channel (7) PPAR (6) Progesterone Receptor (9) Prostaglandin Receptor (2) Proteasome (1) Proton Pump (11) PTHR (1) Raf (5) RAR/RXR (2) Ras (1) Reactive Oxygen Species (13) RET (2) Reverse Transcriptase (2) RSV (1) SARS-CoV (9) Ser/Thr Protease (1) Serotonin Transporter (12) Sigma Receptor (2) Sirtuin (1) Small Interfering RNA (siRNA) (9) Smo (1) Sodium Channel (13) STAT (8) Stearoyl-CoA Desaturase (SCD) (1) Tau Protein (1) Thrombin (3) Thymidylate Synthase (1) Thyroid Hormone Receptor (3) TMV (1) TNF Receptor (1) TOPK (1) Topoisomerase (5) Transthyretin (TTR) (1) Trk Receptor (3) TRP Channel (5) TSH Receptor (1) Tyrosinase (2) Vasopressin Receptor (1) VD/VDR (61) VEGFR (11) Virus Protease (4) Wnt (1) β-catenin (1) γ-secretase (1)
By Research Areas:	Cancer (358) Cardiovascular Disease (83) Endocrinology (100) Infection (152) Inflammation/Immunology (167) Metabolic Disease (171) Neurological Disease (325)
Click Chemistry:	Azide (3) Alkynes (2)
Oligonucleotides:	miRNA mimics (16) miRNA agomirs (16) miRNA antagomirs (16) Nucleosides and their Analogs (11) MicroRNAs (64) Pre-designed siRNA Sets (9) miRNA inhibitors (16) siRNAs (9)

1843

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

1525

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

*D-3*	Phosphatase	Cancer
D-3, a phosphorpeptide, is an efficient, simple, and specific iPSC-eliminating agent .

D3-βArr	TSH Receptor	Endocrinology
D3-βArr is a positive allosteric modulator for thyrotropin receptor (TSHR), which initiates translocation of β-Arr 1 by direct TSHR activation and potentiates TSH-mediated preosteoblast differentiation in vitro .

D-(-)-3-Phosphoglyceric acid disodium 3-Phospho-D-glyceric acid disodium	Enolase	Infection
D-(-)-3-Phosphoglyceric acid (3-Phospho-D-glyceric acid) disodium is an important intermediate in the enzyme-catalysed process of glycolysis. D-(-)-3-Phosphoglyceric acid disodium competitively inhibits yeast enolase .

D-(+)-Phenyllactic acid D-3-Phenyllactic acid	Bacterial Endogenous Metabolite	Infection
D-(+)-Phenyllactic acid is an anti-bacterial agent, excreted by Geotrichum candidum, inhibits a range of Gram-positive from humans and foodstuffs and Gram-negative bacteria found in humans .

D3S-001	Ras	Cancer
D3S-001 is an orally active inhibitor for KRAS. D3S-001 inhibits the proliferation of KRAS ^G12C mutant H358 and MIA-PA-CA-2 with an IC₅₀ of 0.6 and 0.44 nM. D3S-001 exhibits good metabolic stability in hepatocytes, liver microsomes, plasma and whole blood in various species. D3S-001 exhibits good pharmacokinetic characteristics and antitumor efficacy in mice .

D3R/MOR antagonist 2	Dopamine Receptor Opioid Receptor	Inflammation/Immunology
D3R/MOR antagonist 2 (Compound 121) is a *D3R/MOR* antagonist (K_i: 361 nM and 85.2 nM respectively). D3R/MOR antagonist 2 has the potential to produce analgesic effects through MOR partial agonism, reduce opioid-misuse liability via D3R antagonism .

D3R/MOR antagonist 1	Dopamine Receptor Opioid Receptor	Inflammation/Immunology
D3R/MOR antagonist 1 (Compound 114) is a *D3R/MOR* antagonist (K_i: 46.5 nM and 691 nM respectively). D3R/MOR antagonist 1 has the potential to produce analgesic effects through MOR partial agonism, reduce opioid-misuse liability via D3R antagonism .

D3R ligand 1	Dopamine Receptor	Neurological Disease
D3R ligand 1 (compound 23b) is a potent and selective ligand of dopamine receptor *D3R* (Ki=66 nM), containing a THPB template. D3R ligand 1 is also an antagonist for both G-protein- and β-arrestin-based signaling .

3-(2-Thienyl)-D-alanine D-3-(2-Thienyl)alanine	Amino Acid Derivatives	Others
3-(2-Thienyl)-D-alanine is an alanine derivative .

Pre-vitamin D3 decanoate	VD/VDR	Others
Pre-vitamin D3 decanoate is a derivative of vitamin D3 that can be converted into the active form of vitamin D in the body. Pre-vitamin D3 decanoate is first converted to 25-hydroxyvitamin D3 in the liver and then further converted to 1,25-dihydroxyvitamin D3 in the kidneys. During preparation, vitamin D3 may react with the triglycerides in the formulation to form ester compounds, and this esterification affects the stability and bioavailability of vitamin D3. Pre-vitamin D3 decanoate can be used in the study of certain diseases associated with vitamin D, such as osteoporosis, autoimmune diseases, and certain cancers .

23,25-Dihydroxy-24-oxovitamin D3 24-Oxo-23,25-dihydroxyvitamin D3	Endogenous Metabolite	Metabolic Disease
23,25-Dihydroxy-24-oxovitamin D3 is a major metabolite of 24(R),25-Dihydroxyvitamin D3. 23,25-Dihydroxy-24-oxovitamin D3 can be used for the research of metabolic diseases .

1α,25-Dihydroxyprevitamin D3	Others	Others
1α,25-Dihydroxyprevitamin D3 is the precursor of Vitamin D3 .

3-epi-Vitamin D3 Epicholecalciferol	Hedgehog	Cancer
3-epi-Vitamin D3 (Epicholecalciferol) (Compound 4), a Vitamin D3 analogue, is a Hedgehog pathway inhibitor with an IC₅₀ of 39.2 μM measured in U87MG cells .

Previtamin D3	VD/VDR	Metabolic Disease
Previtamin D3 is an intermediate in the production of cholecalciferol (vitamin D3) .

Vitamin D3 octanoate	Endogenous Metabolite	Others
Vitamin D3 octanoate is an octanoate ester of vitamin D3 . Vitamin D3 (Cholecalciferol; HY-15398) is a naturally occuring form of vitamin D. Vitamin D3 induces cell differentiation and prevents proliferation of cancer cells .

Vitamin D3 (Standard)	VD/VDR Endogenous Metabolite Bacterial	Metabolic Disease Cancer
Vitamin D3 (Standard) is the analytical standard of Vitamin D3. This product is intended for research and analytical applications. Vitamin D3 (Cholecalciferol; Colecalciferol) is a naturally occuring form of vitamin D. Vitamin D3 induces cell differentiation and prevents proliferation of cancer cells.

Safinamide d3	Isotope-Labeled Compounds	Others
Safinamide d₃ is the deuterium labeled Safinamide[1].

Resolvin D3 RvD3	Others	Inflammation/Immunology
Resolvin D3 (RvD3) is a docosahexaenoic acid (DHA) derived mediator. Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation .

Platycodin D3	HCV	Infection
Platycodin D3 is a triterpenoid saponin isolated from Platycodon grandiflorum, with anti-HCV activity .

Vitamin D3 5+ Cited Publications Cholecalciferol; Colecalciferol	VD/VDR Endogenous Metabolite Bacterial	Metabolic Disease Cancer
Vitamin D3 (Cholecalciferol; Colecalciferol) is a naturally occuring form of vitamin D. Vitamin D3 induces cell differentiation and prevents proliferation of cancer cells.

Polygalacin D3	PI3K Akt Apoptosis	Cancer
Polygalacin D3 is a triterpenoid saponin compound that can be extracted from the roots of the balloon flower. Polygalacin D3 can inhibit the proliferation of non-small cell lung cancer (NSCLC) cell lines by blocking the *PI3K/Akt* pathway, and it induces cell cycle arrest and cell apoptosis .

5,6-trans-Vitamin D3 5,6-trans-Cholecalciferol; 5,6-trans-Colecalciferol; Cholecalciferol EP Impurity A	VD/VDR	Metabolic Disease
5,6-trans-Vitamin D3 (5,6-trans-Cholecalciferol;5,6-trans-Colecalciferol) is a photoproduct of vitamin D3 . Vitamin D3 is a naturally occuring form of vitamin D. Vitamin D3 induces cell differentiation and prevents proliferation of cancer cells.

Deapi-platycodin D3 1 Publications Verification	Others	Metabolic Disease Inflammation/Immunology
Deapi-platycodin D3 is a triterpenoid saponin from the roots of Platycodon grandiflorum .

Slingshot inhibitor D3	Others	Infection Cancer
Slingshot inhibitor D3 is a potent, selective, reversible and competitive inhibitor of Slingshot. The IC₅₀ value for Slingshot 1 is 3 μM and the K_i value for Slingshot 2 is 3.9 μM. Slingshot inhibitor D3 has similar inhibitory activities toward both Slingshot 1 and Slingshot 2 .

3-O-(2-Aminoethyl)-25-hydroxyvitamin D3 25-Hydroxy Vitamin D3 3,3’-Aminopropyl Ether	VD/VDR	Metabolic Disease
3-O-(2-Aminoethyl)-25-hydroxyvitamin D3 is a Vitamin D3 derivative.

Dopamine D3 receptor antagonist-2	Dopamine Receptor	Neurological Disease
Dopamine D3 receptor antagonist-2 is a dopamine D3 receptor-selective (K_i = 2.16 nM) or multitarget bitopic ligand potentially useful for central nervous system disorders.

Dopamine D3 receptor antagonist-1	Dopamine Receptor	Neurological Disease
Dopamine D3 receptor antagonist-1 is a dopamine D₃ receptor-selective or multitarget bitopic ligand (K_i = 1.58 nM) potentially useful for central nervous system disorders.

Tacalcitol 2 Publications Verification 1,24(R)-Dihydroxyvitamin D3; 1.alpha.,24R-Dihydroxyvitamin D3	VD/VDR	Metabolic Disease
Tacalcitol (1,24(R)-Dihydroxyvitamin D3; 1.

Butyrate-Vitamin D3 Butyrate-Cholecalciferol; Butyrate-Colecalciferol	VD/VDR	Metabolic Disease Inflammation/Immunology Cancer
Butyrate-Vitamin D3 (Butyrate-Cholecalciferol) is a derivative of vitamin D3 in which a hydroxyl group in the vitamin D3 molecule is replaced by a butyric acid group. Butyrate-Vitamin D3 affects gene expression and cell function and has certain anti-inflammatory effects. Butyrate-Vitamin D3 can be used in the study of immune regulation, metabolic diseases and cancer .

22-Hydroxyvitamin D3	VD/VDR	Metabolic Disease
22-Hydroxyvitamin D3 a novel vitamin D analog, that displays no vitamin D agonist activity in the intestine or in bone .

Prostaglandin D3 PGD3	Prostaglandin Receptor	Cardiovascular Disease
Prostaglandin D3 (PGD3) is a prostaglandin that acts as an inhibitor of platelet aggregation and a modulator of autonomic neurotransmission in humans .

25,26-Dihydroxyvitamin D3 25,26-Dihydroxycholecalciferol	VD/VDR Endogenous Metabolite	Others
25,26-Dihydroxyvitamin D3(25,26-dihydroxycholecalciferol) is a metabolite of vitamin D3 with intestinal calcium transport activity.

Tacalcitol monohydrate 1,24(R)-Dihydroxyvitamin D3 monohydrate	VD/VDR	Metabolic Disease
Tacalcitol monohydrate (1,24(R)-Dihydroxyvitamin D3; 1.

1α-Hydroxy-3-epi-vitamin D3	Thyroid Hormone Receptor	Metabolic Disease
1α-Hydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone (PTH) secretion .

Doxepin D3 Hydrochloride	Histamine Receptor Cytochrome P450	Neurological Disease
Doxepin-d₃ (hydrochloride) is a deuterium labeled Doxepin Hydrochloride. Doxepin hydrochloride is an orally active tricyclic antidepressant. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[1][2].

2-Methylthiopurine-13C, d3	Isotope-Labeled Compounds	Others
2-Methylthiopurine- ¹³C,d₃ is the deuterium and ¹³C labeled 2-Methylthiopurine[1].

(E)-1α,25-Dihydroxyprevitamin D3	Others	Others
(E)-1α,25-Dihydroxyprevitamin D3 is a structurally related analog of 1α,25(OH)2D3 .

(24S)-24,25-Dihydroxyvitamin D3 (24S)-24,25-Dihydroxycholecalciferol	VD/VDR	Others
(24S)-24,25-Dihydroxyvitamin D3 ((24S)-24,25-Dihydroxycholecalciferol) is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs.

Calcifediol 5+ Cited Publications 25-hydroxy Vitamin D3	VD/VDR Endogenous Metabolite	Metabolic Disease
Calcifediol (25-hydroxy Vitamin D3) is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels ^[3].

Calcifediol monohydrate 5+ Cited Publications 25-hydroxy Vitamin D3 monohydrate	VD/VDR Endogenous Metabolite	Metabolic Disease
Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate), is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels ^[3].

Alosetron D3 Hydrochloride GR-68755C d₃	5-HT Receptor	Neurological Disease
Alosetron-d₃ (hydrochloride) is deuterium labeled Alosetron, which is a serotonin 5HT3-receptor antagonist.

Albendazole sulfoxide D3 Ricobendazole d₃; Albendazole oxide d₃	Parasite	Inflammation/Immunology
Albendazole sulfoxide-d₃ is deuterium labeled Albendazole sulfoxide, which is a broad-spectrum anthelmintic.

Chol-5-en-24-al-3β-ol Vitamin D3 derivative	VD/VDR	Metabolic Disease
Chol-5-en-24-al-3β-ol is a steroid compound (Vitamin D3 derivative) extracted from patent US 4354972 A, Compound IX.

Sulfadoxine D3 Sulphadoxine d₃	Parasite Antibiotic	Infection
Sulfadoxine-d₃ is a deuterium labeled Sulfadoxine (HY-B0439). Sulfadoxine is a sulfonamide that is used, usually in combination with Pyrimethamine (HY-18062), for multidrug-resistant Plasmodium falciparum and P. vivax inhibition. Unlike PYR, Sulfadoxine has no impact on HIV replication or MT-2 cell cycle progression. But also Sulfadoxine exhibits suppression on respiratory, and urinary tract infections[1][2][3][4].

(S)-(+)-Ibuprofen D3 (S)-Ibuprofen d₃	COX	Inflammation/Immunology
(S)-(+)-Ibuprofen-d₃ is a deuterium labeled (S)-(+)-Ibuprofen. (S)-(+)-Ibuprofen is the S(+)-enantiomer of Ibuprofen that inhibits COX-1 and COX-2 activity with IC50s of 2.1 μM and 1.6 μM. (S)-(+)-Ibuprofen has analgesic, antiinflammatory and antipyretic effects[1][2].

Secalciferol 3 Publications Verification (24R)-24,25-Dihydroxyvitamin D3	Endogenous Metabolite VD/VDR	Metabolic Disease Inflammation/Immunology
Secalciferol ((24R)-24,25-Dihydroxyvitamin D3) is the major active metabolite of Vitamin D. Secalciferol activates vitamin D receptor (VDR) with an EC₅₀ value of 150 nM. Secalciferol is involved in a wide range of biological functions such as calcium homeostasis, cellular differentiation and proliferation processes, as well as other functions related to the immune system, which is promising for research of rickets, osteomalacia, hypercalcemia and autoimmune disorders ^[3] .

Cat. No.	Product Name

HY-L165

Dopamine Receptor Compound Library

209 compounds

Dopamine receptor (DAR), widely distributed in the brain, plays a key role in regulating motor function, motivation, driving force and cognition. The role of DA is mediated by D1-type (D1, D5) and D2-type receptors (D2S, D2L, D3, D4), which are distributed in presynaptic, postsynaptic and extrasynaptic, projection neurons and interneurons. Each receptor has a different function. D1 and D5 receptors couple with G stimulation sites and activate Adenylyl cyclase. The activation of Adenylyl cyclase leads to the production of the second messenger cAMP, which leads to the production of protein kinase A (PKA), which leads to further transcription in the nucleus. D2 to D4 receptors are coupled to G inhibitory sites to inhibit adenylyl cyclase and activate potassium Ion channel. These receptors utilize phosphorylation cascades or direct membrane interactions to affect the functions of voltage-gated and neurotransmitter-gated channels, cytoplasmic enzymes, and transcription factors. Dopamine receptor plays an important role in daily life.

MCE designs a unique collection of 209 small molecules related to dopamine receptor. It is a good tool for screening drugs from nervous system disease.

Cat. No.	Product Name	Type

HY-112624I

Dextran T3 (MW 3,000) Dextran 3; Dextran D3; Dextran T3(MW 2400-3600)	Thickeners
Dextran T3 MW 3,000 (Dextran D3; Dextran T3 MW 2400-3600) is a polymer of anhydroglucose with the average molecular weight of 3000. Dextran T3 MW 3,000 exhibits good biodegradability and good biocompatibility, that is utilized in food, pharmaceutics, cosmetics, and research area .

HY-158285

25-OH Vitamin D3/BSA	Biochemical Assay Reagents
25-OH Vitamin D3/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-161551

25-OH Vitamin D3/KLH	Biochemical Assay Reagents

HY-W127357

Tripelargonin

Drug Delivery

Glyceryl trinonanoate is a triacylglycerol containing nonanoic acid at the sn-1, sn-2 and sn-3 positions. It has been found in Schizochytrium biomass. 1 1,2,3-Trinonanoyl-rac-glycerol increases blood levels of the ketone body D-(-)-3-hydroxybutyrate in neonatal rhesus monkeys. 2|1. Mioso, R., Toledo Marante, FJ, González, JE, et al. Schizochytrium sp. metabolite analysis. Oleaginous microbial sources of biodiesel by GC-MS. braz. J. Microbiology. 45(2), 403-409 (2014).|2. Tetrick, MA, Greer, FR and Benevenga, NJ Blood D- ( )-3-Hydroxybutyric acid concentration. Compare. medicine. 60(6), 486-490 (2010).

Cat. No.	Product Name	Target	Research Area

HY-P2286

*D-3*	Phosphatase	Cancer
D-3, a phosphorpeptide, is an efficient, simple, and specific iPSC-eliminating agent .

HY-P1083

Dynamin inhibitory peptide	Dynamin	Neurological Disease
Dynamin inhibitory peptide competitively blocks binding of dynamin to amphiphysin, thus preventing endocytosis. Dynamin inhibitory peptide blocks the dopamine D3 effect on GABAA receptors .

HY-W008922

*Fmoc-D-3,3-diphenylalanine*	Amino Acid Derivatives	Others
Fmoc-D-3,3-diphenylalanine is a peptide derivative.

HY-I0423

3-(2-Thienyl)-D-alanine D-3-(2-Thienyl)alanine	Amino Acid Derivatives	Others
3-(2-Thienyl)-D-alanine is an alanine derivative .

HY-P1083A

Dynamin inhibitory peptide TFA	Dynamin	Neurological Disease
Dynamin inhibitory peptide TFA competitively blocks binding of dynamin to amphiphysin, thus preventing endocytosis. Dynamin inhibitory peptide TFA blocks the dopamine D₃ effect on GABA_A receptors .

HY-W013874

*Boc-D-3-Pal-OH*	Amino Acid Derivatives	Others
Boc-D-3-Pal-OH is an alanine derivative .

HY-P4010

*Desamino(D-3-(3′-pyridyl)-Ala2,Arg8)-Vasopressin*	Vasopressin Receptor	Others
Desamino(D-3-(3′-pyridyl)-Ala2,Arg8)-Vasopressin, a synthetic analog of vasopressin (AVP), is a weak agonist at antidiuretic receptor. However, Desamino(D-3-(3′-pyridyl)-Ala2,Arg8)-Vasopressin is a potent agonist at pituitary corticotrope receptor .

HY-P10299

Calcitonin, porcine	Peptides	Others
Calcitonin, porcine inhibits 1,25 (OH)₂D₃-stimulated porcine osteoclast differentiation. Calcitonin is a polypeptide hormone that can lower serum calcium by decreasing calcium reabsorption in the kidney and inhibiting osteoclastic bone resorption. Calcitonin, porcine can be used for research of hypercalcemia .

HY-W042005

H-D-Phe(3,4-DiCl)-OH	Amino Acid Derivatives	Others
H-D-Phe(3,4-DiCl)-OH is D-3,4-Dichlorophenylalanine, a amino acid derivative. H-D-Phe(3,4-DiCl)-OH shows protein synthesis activity .

HY-W044285

Fmoc-D-4-Aph(cBm)-OH	Amino Acid Derivatives	Others
Fmoc-D-4-Aph(cBm)-OH is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize biologically active peptide mimetics, such as Ac-D2Nal-D4Cpa-D3Pal-Ser-4Aph/4Amf(P)-D4Aph/D4Amf(Q)-Leu-ILys-Pro-DAla-NH2 with gonadotropin-releasing hormone (GnRH) antagonist activity .

Cat. No.	Product Name	Target	Research Area

HY-P99976

Anti-Mouse CD19 Antibody (1D3)	CD19	Cancer
Anti-Mouse CD19 Antibody (1D3) is an anti-mouse CD19 IgG2a antibody inhibitor.

HY-P990129

Anti-Mouse CD71/TfR1 Antibody (8D3)	Inhibitory Antibodies	Others
Anti-Mouse CD71/TfR1 Antibody (8D3) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse CD71/TfR1.

Species:	Human (10) Mouse (2)
Tag:	His (7) Tag Free (3) Strep (1) GST (3) Flag (1)
Source:	HEK293 (2) Sf9 insect cells (7) E. coli (3)

Cat. No.	Compare	Product Name	Species	Source

HY-P74633A

	PHGDH Protein, Human (C-His) D-3-phosphoglycerate dehydrogenase; 3-PGDH; 2-oxoglutarate reductase; PGDH3	Human	E. coli
	PHGDH protein plays a key role in cellular metabolism by catalyzing the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, marking the first step in the phosphorylated L-serine biosynthetic pathway.PHGDH Protein, Human (C-His) is the recombinant human-derived PHGDH protein, expressed by E.coli , with C-6*His labeled tag.

HY-P701103

	MSP/MST1 Protein, Mouse (C677A, HEK293) Hepatocyte growth factor-like protein; MST1; Macrophage stimulatory protein; Macrophage-stimulating protein; MSP; D3F15S2; DNF15S2; HGFL; Macrophage Stimulating Protein/Macrophage Stimulating 1 [Hepatocyte Growth Factor-like] ; Macrophage Stimulating Prot	Mouse	HEK293
	The MSP/MST1 protein, encoded by this gene, is predicted to have receptor tyrosine kinase binding activity. It is involved in various processes, including embryo implantation, mammary duct growth, and regulation of mammary gland cell proliferation. The protein is mainly found in the vacuole and expressed in tissues like the esophagus, liver, pharynx, and stomach. Notably, the gene shows liver-biased expression in both adult and embryonic stages. MSP/MST1 Protein, Mouse (C677A, HEK293) is the recombinant mouse-derived MSP/MST1 protein, expressed by HEK293 , with tag free. and C677A, , , , mutation.

HY-P70998

	UBE2D3 Protein, Human 2 Publications Verification Ubiquitin-conjugating enzyme E2 D3; Ubiquitin carrier protein D3; Ubiquitin-conjugating enzyme E2(17)KB 3; Ubiquitin-conjugating enzyme E2-17 kDa 3; Ubiquitin-protein ligase D3; UBE2D3 and UBCH5C.	Human	E. coli
	Ubiquitin-conjugating enzyme E2 D3 (UBE2D3) is an E3 ubiquitin protein ligase. UBE2D3 is able to accept ubiquitin from specific E2 ubiquitin-conjugating enzymes and transfer it to substrates, often promoting its degradation by the proteasome. UBE2D3 Protein, Human is the recombinant human-derived UBE2D3 protein, expressed by E. coli , with tag free. The total length of UBE2D3 Protein, Human is 147 a.a., with molecular weight of ~15.0 kDa.

HY-P73543

	Vitamin D Receptor/VDR Protein, Human (sf9, His) Vitamin D3 receptor; VDR; NR1I1	Human	Sf9 insect cells
	Vitamin D receptor (VDR) acts as a nuclear receptor for calcitriol, the active form of vitamin D3, triggering cellular effects. After vitamin D3 binding, VDR translocates to the nucleus and forms a heterodimer with the retinoid X receptor (RXR). Vitamin D Receptor/VDR Protein, Human (sf9, His) is the recombinant human-derived Vitamin D Receptor/VDR protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Vitamin D Receptor/VDR Protein, Human (sf9, His) is 427 a.a., with molecular weight of ~50 kDa.

HY-P703117

	DRD3 Protein, Human (HEK293, Flag, His) D(3) dopamine receptor; Dopamine D3 receptor; DRD3; Homo sapiens; Human; G-protein coupled receptor; Receptor; Transducer	Human	HEK293

HY-P702065

	UB2D3 Protein, Human (Sf9, His, Strep) UBE2D3; Ubiquitin-conjugating enzyme E2 D3; (E3-independent) E2 ubiquitin-conjugating enzyme D3; E2 ubiquitin-conjugating enzyme D3; Ubiquitin carrier protein D3; Ubiquitin-conjugating enzyme E2(17)KB 3; Ubiquitin-conjugating enzyme E2-17 kDa 3; Ubiquitin-protein ligase D3	Human	Sf9 insect cells
	The UBE2D3 protein is a key player in ubiquitination. It accepts ubiquitin from the E1 complex and covalently attaches it to a variety of proteins, demonstrating multifunctionality. It catalyzes "Lys-11" and "Lys-48" linked polyubiquitination in vitro, regulating protein ubiquitination patterns. UB2D3 Protein, Human (Sf9, His, Strep) is the recombinant human-derived UB2D3 protein, expressed by Sf9 insect cells , with N-Strep, N-8*His labeled tag. The total length of UB2D3 Protein, Human (Sf9, His, Strep) is 146 a.a., .

HY-P73542

	Vitamin D Receptor/VDR Protein, Mouse (sf9, His) Vitamin D3 receptor; VDR; NR1I1	Mouse	Sf9 insect cells
	Vitamin D receptor (VDR) protein is the nuclear receptor of calcitriol, which translocates to the nucleus after binding vitamin D3, thereby coordinating cellular activities.VDR forms a heterodimer with RXR, binds to DNA response elements, and initiates the transcription of vitamin D3-responsive genes.Vitamin D Receptor/VDR Protein, Mouse (sf9, His) is the recombinant mouse-derived Vitamin D Receptor/VDR protein, expressed by Sf9 insect cells , with C-His labeled tag.

HY-P73699

	PRKD3/nPKC nu Protein, Human (sf9, GST) Serine/threonine-protein kinase D3; nPKC-nu; PRKD3; EPK2; PRKCN	Human	Sf9 insect cells
	PRKD3/nPKC nu protein acts as a mediator in the conversion of transient diacylglycerol (DAG) signals into sustained physiological effects, functioning downstream of PKC.Additionally, it plays a crucial role in conferring resistance to oxidative stress, demonstrating its involvement in cellular responses to environmental challenges.PRKD3/nPKC nu Protein, Human (sf9, GST) is the recombinant human-derived PRKD3/nPKC nu protein, expressed by Sf9 insect cells , with GST labeled tag.

HY-P702957

	CCND3 Protein, Human (sf9, GST) G1/S-specific cyclin-D3; CCND3	Human	Sf9 insect cells

HY-P701369

	CDK6-CCND3 Heterodimer Protein, Human (Sf9) CDK6; CCND3; Cyclin-dependent kinase 6; Cell division protein kinase 6; Serine/threonine-protein kinase PLSTIRE; G1/S-specific cyclin-D3	Human	Sf9 insect cells
	The CDK6ic complex is an important serine/threonine protein kinase that regulates cell cycle progression and differentiation, promoting the G1/S transition by phosphorylating substrates such as pRB/RB1 and NPM1. It interacts with D-type G1 cyclins during interphase to form active pRB/RB1 kinase, which controls cell cycle entry. CDK6-CCND3 Heterodimer Protein, Human (Sf9) is a recombinant protein dimer complex containing human-derived CDK6-CCND3 Heterodimer protein, expressed by Sf9 insect cells , with tag free.

HY-P701370

	CDK6-CCND3 Heterodimer Protein, Human (Sf9, GST, His) CDK6; CCND3; Cyclin-dependent kinase 6; Cell division protein kinase 6; Serine/threonine-protein kinase PLSTIRE; G1/S-specific cyclin-D3	Human	Sf9 insect cells
	The CDK6ic complex is an important serine/threonine protein kinase that regulates cell cycle progression and differentiation, promoting the G1/S transition by phosphorylating substrates such as pRB/RB1 and NPM1. It interacts with D-type G1 cyclins during interphase to form active pRB/RB1 kinase, which controls cell cycle entry. CDK6-CCND3 Heterodimer Protein, Human (Sf9, GST, His) is a recombinant protein dimer complex containing human-derived CDK6-CCND3 Heterodimer protein, expressed by Sf9 insect cells , with N-10*His, N-GST labeled tag.

HY-P71411

	UBE2V2 Protein, Human (His) Ubiquitin-Conjugating Enzyme E2 Variant 2; DDVit 1; Enterocyte Differentiation-Associated Factor 1; EDAF-1; Enterocyte Differentiation-Promoting Factor 1; EDPF-1; MMS2 Homolog; Vitamin D3-Inducible Protein; UBE2V2; MMS2; UEV2	Human	E. coli
	UBE2V2 protein lacks independent ubiquitin ligase activity and forms a functional heterodimer with UBE2N. Together, they catalyze nonclassical polyubiquitin chain synthesis ("Lys-63"), distinct from proteasome-driven degradation. UBE2V2 Protein, Human (His) is the recombinant human-derived UBE2V2 protein, expressed by E. coli , with N-6*His labeled tag. The total length of UBE2V2 Protein, Human (His) is 145 a.a., with molecular weight of ~18.0 kDa.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81997

	Dopamine Receptor D3 Antibody (YA1742) D(3) dopamine receptor; Dopamine D3 receptor; DRD3; ETM1; FET1	WB	Human, Mouse, Rat
	Dopamine Receptor D3 Antibody (YA1742) is a biotin-conjugated non-conjugated IgG antibody, targeting Dopamine Receptor D3, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). Dopamine Receptor D3 Antibody (YA1742) can be used for WB experiment in human, mouse, rat background.

HY-P80099

	Cyclin D3 Antibody	WB, ICC/IF, FC	Human, Mouse
	Cyclin D3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Cyclin D3. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.

HY-P81203

	Vitamin D Receptor Antibody Vitamin D3 receptor; 125 dihydroxyvitamin D3 receptor; 1 antibody 1,25-@dihydroxyvitamin D3 receptor; 125 dihydroxyvitamin D3 receptor; 25-dihydroxyvitamin D3 receptor; NR1I1; Nuclear receptor subfamily 1 group I member 1; VDR; VDR_HUMAN; Vitamin D (1,25- dihydroxyvitamin D3) receptor; Vitamin D hormone receptor; Vitamin D receptor; Vitamin D3 receptor,	IHC-P, IHC-F, ICC/IF	Human, Rat
	Vitamin D Receptor Antibody is an unconjugated, approximately 47 kDa, rabbit-derived, anti-Vitamin D Receptor polyclonal antibody. Vitamin D Receptor Antibody can be used for: IHC-P, IHC-F, ICC, IF expriments in human, rat, and predicted: mouse, chicken, pig, cow, horse, rabbit background without labeling.

HY-P82913

	DCI Antibody (YA2658) ECI1; DCI; Enoyl-CoA delta isomerase 1; mitochondrial; 3; 2-trans-enoyl-CoA isomerase; Delta(3); Delta(2)-enoyl-CoA isomerase; D3; D2-enoyl-CoA isomerase; Dodecenoyl-CoA isomerase	WB, IHC-F, IHC-P, ICC/IF	Human, Mouse, Rat
	DCI Antibody (YA2658) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2658), targeting DCI, with a predicted molecular weight of 33 kDa (observed band size: 33 kDa). DCI Antibody (YA2658) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.

HY-P80751

	Mitofusin 1 Antibody HR2; mKIAA4032; D3Ertd265e; 2310002F04Rik; 6330416C07Rik	WB, IP	Mouse, Rat, Hamster
	Mitofusin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Mitofusin 1. It can be used for WB,IP assays with tag free, in the background of Mouse, Rat, Hamster.

HY-P82588

	Ubiquitin Conjugating Enzyme E2 D3 Antibody (YA2333) ubiquitin conjugating enzyme E2D 3; UBC4/5; UBCH5C; E2(17)KB3	WB, IP	Human, Mouse, Rat
	Ubiquitin Conjugating Enzyme E2 D3 Antibody (YA2333) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2333), targeting Ubiquitin Conjugating Enzyme E2 D3, with a predicted molecular weight of 17 kDa (observed band size: 17 kDa). Ubiquitin Conjugating Enzyme E2 D3 Antibody (YA2333) can be used for WB, IP experiment in human, mouse, rat background.

HY-P82376

	Cytochrome P450 24A1 Antibody (YA2121) CYP24A1; CYP24; 1; 25-dihydroxyvitamin D(3) 24-hydroxylase; mitochondrial; 24-OHase; Vitamin D(3) 24-hydroxylase; Cytochrome P450 24A1; Cytochrome P450-CC24	WB	Human
	Cytochrome P450 24A1 Antibody (YA2121) is a biotin-conjugated non-conjugated IgG antibody, targeting Cytochrome P450 24A1, with a predicted molecular weight of 59 kDa (observed band size: 59 kDa). Cytochrome P450 24A1 Antibody (YA2121) can be used for WB experiment in human background.

HY-P82418

	Cytochrome P450 27A1 Antibody (YA2163) CYP27A1; CYP27; Sterol 26-hydroxylase; mitochondrial; 5-beta-cholestane-3-alpha; 7-alpha; 12-alpha-triol 27-hydroxylase; Cytochrome P-450C27/25; Cytochrome P450 27; Sterol 27-hydroxylase; Vitamin D(3) 25-hydroxylase	WB, IHC-P, ICC/IF, FC	Human, Mouse, Rat
	Cytochrome P450 27A1 Antibody (YA2163) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2163), targeting Cytochrome P450 27A1, with a predicted molecular weight of 60 kDa (observed band size: 50 kDa). Cytochrome P450 27A1 Antibody (YA2163) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.

HY-P81456

	Cyclin D3/CCND3 Antibody (YA1201) CCND3 ; G1/S-specific cyclin-D3	IHC-P	Human
	Cyclin D3/CCND3 Antibody (YA1201) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1201), targeting Cyclin D3/CCND3. Cyclin D3/CCND3 Antibody (YA1201) can be used for IHC-P experiment in human background.

HY-P82281

	SNRPD3 Antibody (YA2026) SMD3; Sm-D3	WB	Human, Rat
	SNRPD3 Antibody (YA2026) is a biotin-conjugated non-conjugated IgG antibody, targeting SNRPD3, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). SNRPD3 Antibody (YA2026) can be used for WB experiment in human, rat background.

HY-P81286

	LYRIC Antibody (YA995) MTDH; AEG1; LYRIC; Protein LYRIC; 3D3/LYRIC; Astrocyte elevated gene-1 protein; AEG-1; Lysine-rich CEACAM1 co-isolated protein; Metadherin; Metastasis adhesion protein	WB, IHC-P, FC	Human
	LYRIC Antibody (YA995) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA995), targeting LYRIC, with a predicted molecular weight of 64 kDa (observed band size: 64 kDa). LYRIC Antibody (YA995) can be used for WB, IHC-P, FC experiment in human background.

HY-P81286A

	LYRIC Antibody (YA996) MTDH; AEG1; LYRIC; Protein LYRIC; 3D3/LYRIC; Astrocyte elevated gene-1 protein; AEG-1; Lysine-rich CEACAM1 co-isolated protein; Metadherin; Metastasis adhesion protein	WB, IHC-F, IHC-P, ICC/IF, IP	Human
	LYRIC Antibody (YA996) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA996), targeting LYRIC, with a predicted molecular weight of 64 kDa (observed band size: 75 kDa). LYRIC Antibody (YA996) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-17413S

Zidovudine-d3 Azidothymidine-d₃; AZT-d₃; ZDV-d₃		Azide
Zidovudine-d₃ is the deuterium labeled Zidovudine. Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency. Zidovudine-d3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

HY-B1883S

3,5-Dichloro-N-(2-methylbut-3-yn-2-yl)benzamide-d3		Alkynes
3,5-Dichloro-N-(2-methylbut-3-yn-2-yl)benzamide-d₃ is the deuterium labeled 3,5-Dichloro-N-(2-methylbut-3-yn-2-yl)benzamide[1]. 3,5-Dichloro-N-(2-methylbut-3-yn-2-yl)benzamide-d3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-17413S1

Zidovudine-13C,d3 Azidothymidine-¹³C,d₃; AZT-¹³C,d₃; ZDV-¹³C,d₃		Azide
Zidovudine- ¹³C,d₃ is the ¹³C- and deuterium labeled Zidovudine. Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency. Zidovudine-13C,d3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

HY-152389

*6-Methylpurine-β-D-(3-azido-3-deoxy)riboside*		Azide
6-Methylpurine-β-D-(3-azido-3-deoxy)riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc . 6-Methylpurine-β-D-(3-azido-3-deoxy)riboside is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

HY-154425

*2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine*		Alkynes
2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc . 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Cat. No.	Product Name		Classification

HY-R00008

hsa-let-7d-3p mimic		MicroRNAs miRNA mimics
hsa-let-7d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R00335

hsa-miR-181d-3p mimic		MicroRNAs miRNA mimics
hsa-miR-181d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R00521

hsa-miR-302d-3p mimic		MicroRNAs miRNA mimics
hsa-miR-302d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R00541

hsa-miR-30d-3p mimic		MicroRNAs miRNA mimics
hsa-miR-30d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R01570

hsa-miR-518d-3p mimic		MicroRNAs miRNA mimics
hsa-miR-518d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R01591

hsa-miR-519d-3p mimic		MicroRNAs miRNA mimics
hsa-miR-519d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R01599

hsa-miR-520d-3p mimic		MicroRNAs miRNA mimics
hsa-miR-520d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R01679

hsa-miR-548d-3p mimic		MicroRNAs miRNA mimics
hsa-miR-548d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R02699

mmu-miR-181d-3p mimic		MicroRNAs miRNA mimics
mmu-miR-181d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03048

mmu-miR-344d-3p mimic		MicroRNAs miRNA mimics
mmu-miR-344d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03165

mmu-miR-465d-3p mimic		MicroRNAs miRNA mimics
mmu-miR-465d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03172

mmu-miR-466d-3p mimic		MicroRNAs miRNA mimics
mmu-miR-466d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03200

mmu-miR-467d-3p mimic		MicroRNAs miRNA mimics
mmu-miR-467d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03463

mmu-miR-669d-3p mimic		MicroRNAs miRNA mimics
mmu-miR-669d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R04253

rno-miR-181d-3p mimic		MicroRNAs miRNA mimics
rno-miR-181d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI00008

hsa-let-7d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-let-7d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI00335

hsa-miR-181d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-miR-181d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI00521

hsa-miR-302d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-miR-302d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI00541

hsa-miR-30d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-miR-30d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI01570

hsa-miR-518d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-miR-518d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI01591

hsa-miR-519d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-miR-519d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI01599

hsa-miR-520d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-miR-520d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI01679

hsa-miR-548d-3p inhibitor		MicroRNAs miRNA inhibitors
hsa-miR-548d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI02699

mmu-miR-181d-3p inhibitor		MicroRNAs miRNA inhibitors
mmu-miR-181d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03048

mmu-miR-344d-3p inhibitor		MicroRNAs miRNA inhibitors
mmu-miR-344d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03165

mmu-miR-465d-3p inhibitor		MicroRNAs miRNA inhibitors
mmu-miR-465d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03172

mmu-miR-466d-3p inhibitor		MicroRNAs miRNA inhibitors
mmu-miR-466d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03200

mmu-miR-467d-3p inhibitor		MicroRNAs miRNA inhibitors
mmu-miR-467d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03463

mmu-miR-669d-3p inhibitor		MicroRNAs miRNA inhibitors
mmu-miR-669d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI04253

rno-miR-181d-3p inhibitor		MicroRNAs miRNA inhibitors
rno-miR-181d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RS08090

MAP7D3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
MAP7D3 Human Pre-designed siRNA Set A contains three designed siRNAs for MAP7D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS14605

TM2D3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
TM2D3 Human Pre-designed siRNA Set A contains three designed siRNAs for TM2D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS14241

TBC1D3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
TBC1D3 Human Pre-designed siRNA Set A contains three designed siRNAs for TBC1D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS15135

TSC22D3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
TSC22D3 Human Pre-designed siRNA Set A contains three designed siRNAs for TSC22D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS15341

UBE2D3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
UBE2D3 Human Pre-designed siRNA Set A contains three designed siRNAs for UBE2D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS13203

SLC35D3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
SLC35D3 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC35D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS01803

CACNA2D3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
CACNA2D3 Human Pre-designed siRNA Set A contains three designed siRNAs for CACNA2D3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS12824

SH2D3C Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
SH2D3C Human Pre-designed siRNA Set A contains three designed siRNAs for SH2D3C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS14243

TBC1D3B Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
TBC1D3B Human Pre-designed siRNA Set A contains three designed siRNAs for TBC1D3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-R00008A

hsa-let-7d-3p agomir		MicroRNAs miRNA agomirs
hsa-let-7d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R00335A

hsa-miR-181d-3p agomir		MicroRNAs miRNA agomirs
hsa-miR-181d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R00521A

hsa-miR-302d-3p agomir		MicroRNAs miRNA agomirs
hsa-miR-302d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R00541A

hsa-miR-30d-3p agomir		MicroRNAs miRNA agomirs
hsa-miR-30d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R01570A

hsa-miR-518d-3p agomir		MicroRNAs miRNA agomirs
hsa-miR-518d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R01591A

hsa-miR-519d-3p agomir		MicroRNAs miRNA agomirs
hsa-miR-519d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R01599A

hsa-miR-520d-3p agomir		MicroRNAs miRNA agomirs
hsa-miR-520d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R01679A

hsa-miR-548d-3p agomir		MicroRNAs miRNA agomirs
hsa-miR-548d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R02699A

mmu-miR-181d-3p agomir		MicroRNAs miRNA agomirs
mmu-miR-181d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03048A

mmu-miR-344d-3p agomir		MicroRNAs miRNA agomirs
mmu-miR-344d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03165A

mmu-miR-465d-3p agomir		MicroRNAs miRNA agomirs
mmu-miR-465d-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks